Position in INCY
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$236,653,727
-$8,374,197 QoQ
Shares Held
2,514,383
+1.4% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 40.04962648888415.ToString("F0")%
Shared 0.ToString("F0")%
None 59.95037351111585.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Robeco Institutional Asset Management B.V. holds $889,404,646 across 13 Biotechnology names. INCY ranks #2 (26.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
348,787 | $269,486,787 | |
| 2 | INCY |
Incyte Corp
This page
|
2,514,383 | $236,653,727 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
401,644 | $179,350,111 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,289,101 | $55,289,541 | |
| 5 | RPRX |
Royalty Pharma plc
|
944,594 | $45,312,174 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
126,463 | $41,842,812 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
545,135 | $30,794,676 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
123,082 | $23,268,652 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $236,653,727 | 2,514,383 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $245,027,924 | 2,480,793 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $196,707,296 | 2,319,388 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $162,507,779 | 2,386,311 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $84,231,528 | 1,391,107 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $87,082,558 | 1,260,787 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $83,680,352 | 1,265,966 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $72,463,329 | 1,195,370 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $65,613,374 | 1,151,718 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $66,920,137 | 1,065,777 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $50,487,513 | 873,940 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $41,279,220 | 663,120 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $41,700,079 | 577,004 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $27,476,749 | 342,091 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $21,314,804 | 319,850 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $3,550,609 | 46,737 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $2,579,005 | 32,473 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $2,380,582 | 32,433 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $2,122,825 | 30,864 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $2,788,657 | 33,147 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $10,215,395 | 125,697 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $19,202,487 | 220,769 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $23,077,538 | 257,160 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $26,687,435 | 256,684 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $16,863,257 | 230,278 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||